Zoetis Company Insiders

ZTS Stock  USD 149.77  0.21  0.14%   
Slightly above 74% of Zoetis' corporate insiders are selling. The analysis of insiders' sentiment of trading Zoetis Inc stock suggests that many insiders are alarmed at this time. Zoetis employs about 14.1 K people. The company is managed by 42 executives with a total tenure of roughly 259 years, averaging almost 6.0 years of service per executive, having 335.71 employees per reported executive.
Kristin Peck  CEO
Chief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, Director
Juan Alaix  CEO
Chief Executive Officer, Director

Zoetis' Insider Buying Vs Selling

26

 
Selling
 
Buying

Latest Trades

2024-03-18Roxanne LaganoDisposed 923 @ 173.33View
2024-02-12Roxanne LaganoDisposed 363 @ 197.74View
2024-01-18Roxanne LaganoDisposed 923 @ 191.43View
2024-01-09Rick LarsenAcquired @ 195.87
2023-12-14Roxanne LaganoDisposed 2500 @ 200View
2023-11-21Kristin C PeckDisposed 13000 @ 176.84View
2023-11-17Roxanne LaganoDisposed 923 @ 177.46View
2023-10-24Greg StantonDisposed @ 167.12
2023-10-18Roxanne LaganoDisposed 923 @ 172.92View
2023-10-03Markwayne MullinAcquired @ 170.33
2023-09-26Greg StantonAcquired @ 176.87
2023-09-18Roxanne LaganoDisposed 923 @ 179.58View
2023-09-15Heidi C ChenDisposed 9905 @ 180.15View
2023-09-13Markwayne MullinAcquired @ 182
2023-09-01Roxanne LaganoDisposed 923 @ 192.97View
2023-08-22Dan SullivanDisposed @ 181.82
2023-08-09Robert J PolzerDisposed 1179 @ 189.94View
2023-07-21Robert J. WittmanAcquired @ 183.51
2023-07-14Daniel S. GoldmanDisposed @ 172.19
Monitoring Zoetis' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.

Acquired vs Disposed

Filed vs Not Filed

Insider sentiment refers to the collective sentiment or feeling of Zoetis' insiders - typically its officers, directors, and beneficial owners holding more than a certain percentage of the company's stock - about the future prospects of Zoetis Inc. This sentiment is often gauged based on the trading activities of these insiders. If insiders are purchasing more shares of their own company, it may be interpreted as a bullish sentiment, indicating that they believe Zoetis' stock will rise in value. Conversely, if insiders are selling shares, it might be seen as bearish, suggesting they expect the stock price to drop.
  
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

Zoetis' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Zoetis' future performance. Based on our forecasts, it is anticipated that Zoetis will maintain a workforce of slightly above 14100 employees by May 2024.
 
Yuan Drop
 
Covid

Zoetis' latest congressional trading

Congressional trading in companies like Zoetis Inc, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Zoetis by those in governmental positions are based on the same information available to the general public.
2024-02-27Senator Shelley M CapitoAcquired $15K to $50KVerify
2024-01-09Representative Rick LarsenAcquired Under $15KVerify
2024-01-04Senator Markwayne MullinAcquired Under $15KVerify
2023-12-04Representative John CurtisDisposed Under $15KVerify
2023-10-24Representative Greg StantonDisposed Under $15KVerify
2023-08-22Senator Daniel S SullivanAcquired Under $15KVerify
2023-07-21Representative Robert J. WittmanAcquired Under $15KVerify
2023-07-14Representative Daniel GoldmanDisposed Under $15KVerify
2023-05-25Representative Zoe LofgrenDisposed Under $15KVerify
2023-01-10Senator Dan SullivanAcquired Under $15KVerify
2022-10-05Senator Tommy TubervilleAcquired Under $15KVerify
2022-08-26Representative Alan S. LowenthalAcquired $15K to $50KVerify
2022-03-08Representative Dan NewhouseAcquired Under $15KVerify
2022-01-06Representative Kurt SchraderDisposed Under $15KVerify
2021-02-16Representative Peter MeijerDisposed Under $15KVerify
2020-11-25Representative Michael T. McCaulDisposed $15K to $50KVerify
2020-08-07Representative Joe CourtneyDisposed Under $15KVerify
2019-12-18Representative John B. LarsonDisposed $15K to $50KVerify
2015-01-30Senator David A Perdue , JrAcquired $15K to $50KVerify
2015-01-30Senator David PerdueAcquired $15K to $50KVerify

Zoetis Management Team Effectiveness

The company has Return on Asset of 0.1315 % which means that on every $100 spent on assets, it made $0.1315 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.4982 %, implying that it generated $0.4982 on every 100 dollars invested. Zoetis' management efficiency ratios could be used to measure how well Zoetis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Assets is likely to gain to 0.17 in 2024, whereas Return On Tangible Assets are likely to drop 0.12 in 2024. At this time, Zoetis' Intangible Assets are comparatively stable compared to the past year. Net Tangible Assets is likely to gain to about 336.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 5.6 B in 2024.
Net Income Applicable To Common Shares is likely to gain to about 2.6 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 389.2 M in 2024.

Zoetis Workforce Comparison

Zoetis Inc is rated second in number of employees category among related companies. The total workforce of Health Care industry is at this time estimated at about 43,629. Zoetis totals roughly 14,100 in number of employees claiming about 32% of equities under Health Care industry.

Zoetis Profit Margins

The company has Net Profit Margin of 0.27 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.32 %, which entails that for every 100 dollars of revenue, it generated $0.32 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.520.6828
Way Down
Pretty Stable
Operating Profit Margin0.20.3592
Way Down
Slightly volatile
Return On Assets0.170.1641
Sufficiently Up
Slightly volatile
Return On Equity0.320.4691
Way Down
Slightly volatile

Zoetis Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zoetis insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zoetis' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Zoetis insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-06-01
1.0
1
1
 1,436 
 0.00 
2024-03-01
1.125
108
96
 317,311 
 163,215 
2023-12-01
0.8462
11
13
 16,224 
 45,206 
2023-09-01
1.1818
13
11
 18,110 
 40,523 
2023-06-01
0.9
9
10
 19,387 
 45,312 
2023-03-01
3.8148
103
27
 344,058 
 55,007 
2022-12-01
2.5
10
4
 1,822 
 12,212 
2022-09-01
2.0
18
9
 13,625 
 26,171 
2022-06-01
1.8571
13
7
 7,321 
 15,736 
2022-03-01
1.5789
90
57
 426,955 
 278,909 
2021-12-01
0.8235
14
17
 35,585 
 90,513 
2021-09-01
1.0
14
14
 31,311 
 84,309 
2021-06-01
1.0385
27
26
 96,512 
 127,671 
2021-03-01
1.4304
113
79
 1,070,375 
 1,215,929 
2020-12-01
1.0588
18
17
 23,083 
 137,404 
2020-09-01
0.9474
18
19
 25,229 
 65,614 
2020-06-01
1.1333
17
15
 25,959 
 53,818 
2020-03-01
1.0816
106
98
 1,154,649 
 1,504,148 
2019-12-01
0.7742
24
31
 156,609 
 328,763 
2019-09-01
1.125
18
16
 32,005 
 66,655 
2019-06-01
1.0588
18
17
 67,413 
 136,457 
2019-03-01
1.4203
98
69
 1,282,005 
 1,183,609 
2018-12-01
1.1667
14
12
 164,591 
 351,612 
2018-09-01
1.2308
16
13
 209,389 
 420,271 
2018-06-01
3.6667
11
3
 12,549 
 8,789 
2018-03-01
1.375
99
72
 1,101,154 
 843,514 
2017-09-01
2.3333
14
6
 18,357 
 14,505 
2017-06-01
6.0
12
2
 14,077 
 20,598 
2017-03-01
3.625
58
16
 722,788 
 229,522 
2016-12-01
9.0
18
2
 47,860 
 19,889 
2016-09-01
1.25
25
20
 125,723 
 199,397 
2016-06-01
10.0
10
1
 13,446 
 16,850,000 
2016-03-01
3.7857
53
14
 786,310 
 216,905 
2015-12-01
3.0
12
4
 25,312 
 27,269 
2015-09-01
13.0
13
1
 1,552,031 
 1,540,713 
2015-06-01
3.0
9
3
 7,136 
 41,658 
2015-03-01
3.875
31
8
 225,082 
 30,304 
2014-03-01
5.0
45
9
 386,317 
 13,423 

Zoetis Notable Stakeholders

A Zoetis stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zoetis often face trade-offs trying to please all of them. Zoetis' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zoetis' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kristin PeckChief Executive Officer, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy, DirectorProfile
Juan AlaixChief Executive Officer, DirectorProfile
Michael McCallisterNon-Executive Independent Chairman of the BoardProfile
Roman TrawickiExecutive Vice President and Presidentident of Global Manufacturing and SupplyProfile
Roxanne LaganoChief Human Resource Officer, Executive Vice President and Global OperationsProfile
Clinton LewisExecutive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical DiagnosticsProfile
Stefan WeiskopfExecutive Vice President and Area President of the Asia Pacific, Australia and New ZealandProfile
Sherry PudloskiExecutive Vice President - Corporate Affairs and CommunicationsProfile
Catherine KnuppExecutive Vice President, President - Research and DevelopmentProfile
Alejandro BernalExecutive Vice President and Area President of the Europe, Africa and Middle East regionProfile
Joyce LeeExecutive Vice President and Area President of the Canada and Latin America regionProfile
Glenn DavidChief Financial Officer, Executive Vice PresidentProfile
Wetteny JosephChief Financial Officer, Executive Vice President, Head of Business DevelopmentProfile
Sandra BeatyExecutive Vice President - Corporate AffairsProfile
Andrew FentonExecutive Vice President and Chief Digital and Technology OfficerProfile
Heidi ChenExecutive Vice President General Counsel, Corporate SecretaryProfile
Paul HerendeenCFO and Executive VPProfile
William SteereIndependent DirectorProfile
Linda RhodesIndependent DirectorProfile
Frank DAmelioIndependent DirectorProfile
Robert ScullyIndependent DirectorProfile
Sanjay KhoslaIndependent DirectorProfile
Paul BisaroIndependent DirectorProfile
Antoinette LeatherberryIndependent DirectorProfile
Willie ReedIndependent DirectorProfile
William DoyleDirectorProfile
Gregory NordenIndependent DirectorProfile
Louise ParentIndependent DirectorProfile
Steven FrankVice RelationsProfile
Wafaa MamilliExecutive Vice President and Chief Information and Digital OfficerProfile
Timothy BettingtonExecutive Vice President and President U.S. OperationsProfile
Ester BanqueExecutive OperationsProfile
William PriceVP OfficerProfile
Jamie BrannanExecutive DiagnosticsProfile
Jeannette AstorgaExecutive OfficerProfile
Nick AshtonExecutive SupplyProfile
William DorseyVice DiagnosticsProfile
Rimma DriscollCommercial StrategyProfile
Robert KellyExecutive Vice President and President International OperationsProfile
J McFarlandExecutive Vice President and Chief Medical OfficerProfile
Robert PolzerExecutive Vice President and Presidentident of Research and DevelopmentProfile
Abhay NayakExecutive Vice President Head of Strategy and Accelerated Growth BusinessesProfile

About Zoetis Management Performance

The success or failure of an entity such as Zoetis Inc often depends on how effective the management is. Zoetis management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zoetis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zoetis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.23  0.12 
Return On Capital Employed 0.25  0.15 
Return On Assets 0.16  0.17 
Return On Equity 0.47  0.32 
The data published in Zoetis' official financial statements usually reflect Zoetis' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Zoetis Inc. For example, before you start analyzing numbers published by Zoetis accountants, it's critical to develop an understanding of what Zoetis' liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Zoetis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zoetis' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Zoetis' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zoetis Inc. Please utilize our Beneish M Score to check the likelihood of Zoetis' management manipulating its earnings.

Zoetis Workforce Analysis

Traditionally, organizations such as Zoetis use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zoetis within its industry.

Zoetis Manpower Efficiency

Return on Zoetis Manpower

Revenue Per Employee606K
Revenue Per Executive203.4M
Net Income Per Employee166.2K
Net Income Per Executive55.8M
Working Capital Per Employee315.9K
Working Capital Per Executive106M
When determining whether Zoetis Inc is a strong investment it is important to analyze Zoetis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zoetis' future performance. For an informed investment choice regarding Zoetis Stock, refer to the following important reports:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zoetis Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Complementary Tools for Zoetis Stock analysis

When running Zoetis' price analysis, check to measure Zoetis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zoetis is operating at the current time. Most of Zoetis' value examination focuses on studying past and present price action to predict the probability of Zoetis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zoetis' price. Additionally, you may evaluate how the addition of Zoetis to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Is Zoetis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zoetis. If investors know Zoetis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zoetis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.164
Dividend Share
1.5
Earnings Share
5.08
Revenue Per Share
18.527
Quarterly Revenue Growth
0.085
The market value of Zoetis Inc is measured differently than its book value, which is the value of Zoetis that is recorded on the company's balance sheet. Investors also form their own opinion of Zoetis' value that differs from its market value or its book value, called intrinsic value, which is Zoetis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zoetis' market value can be influenced by many factors that don't directly affect Zoetis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zoetis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zoetis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zoetis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.